Department of Clinical Pharmacy, University Medical Centre Utrecht, University Utrecht, The Netherlands.
Department of Nephrology and Hypertension, University Medical Centre Utrecht, University Utrecht, The Netherlands.
Perit Dial Int. 2024 Mar;44(2):145-148. doi: 10.1177/08968608231199735. Epub 2023 Sep 25.
Vancomycin has been reported to cause vancomycin flushing reaction (VFR), a hypersensitivity reaction that mostly occurs after intravenous administration. The incidence of VFR in a patient receiving intraperitoneal vancomycin is rare. We report a case of a female peritoneal dialysis (PD) patient with a PD-related peritonitis who developed VFR after intraperitoneal administration of 2000 mg vancomycin. Seventy-five minutes after instillation, she developed flushing, a pruritic erythema on the upper body and swelling of the lips. Blood results revealed a vancomycin plasma concentration of 54.8 mg/L and a normal tryptase level. During a relapse of her PD-related peritonitis, vancomycin was successfully reintroduced in a 50% reduced dose. No symptoms of VFR developed, and the corresponding vancomycin plasma concentration was 33.6 mg/L. Intraperitoneal treatment was continued with 500 mg vancomycin every 2-3 days with frequently measured, adequate trough levels ranging from 15-22 mg/L. This case illustrates the risk factors for the development of VFR after intraperitoneal administration of vancomycin, namely a high and concentrated loading dose together with a low body weight, a fast peritoneal transport state and peritonitis. Reintroduction of vancomycin after occurrence of VFR is safe, but a lower loading dose or a slower instillation rate is recommended.
万古霉素曾被报道可引起万古霉素 flush 反应(VFR),这是一种主要在静脉给药后发生的过敏反应。腹腔内给予万古霉素的患者中 VFR 的发生率很少见。我们报告了一例女性腹膜透析(PD)患者,其 PD 相关性腹膜炎在给予 2000mg 万古霉素腹腔内给药后发生了 VFR。灌洗 75 分钟后,她出现了潮红、上半身瘙痒性红斑和嘴唇肿胀。血液检查结果显示万古霉素血药浓度为 54.8mg/L,血清胰蛋白酶正常。在 PD 相关性腹膜炎复发时,以 50%的减少剂量成功重新引入了万古霉素。未出现 VFR 症状,相应的万古霉素血药浓度为 33.6mg/L。继续给予 500mg 万古霉素,每 2-3 天腹腔内治疗一次,频繁测量的药物谷浓度维持在 15-22mg/L。该病例说明了腹腔内给予万古霉素后发生 VFR 的危险因素,即高浓度的负荷剂量、体重低、快速的腹膜转运状态和腹膜炎。发生 VFR 后重新引入万古霉素是安全的,但建议使用较低的负荷剂量或较慢的注入速度。